Dexcom Inc reports results for the quarter ended June 30 - Earnings Summary

DexCom

30/07/2025 22:02

Dexcom Inc DXCM.OQ reported quarterly adjusted earnings of 48 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of 43 cents.  The mean expectation of twenty five analysts for the quarter was for earnings of 44 cents per share. Wall Street expected results to range from 40 cents to 49 cents per share.

Revenue rose 15.2% to $1.16 billion from a year ago; analysts expected $1.12 billion.

Dexcom Inc's reported EPS for the quarter was 45 cents​.

The company reported quarterly net income of $179.8 million.

Dexcom Inc shares had risen by 2.4% this quarter and gained 14.9% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had fallen by about 7.6% in the last three months.​

In the last 30 days, two analysts negatively revised earnings estimates

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 24 "strong buy" or "buy," 4 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for Dexcom Inc is $100.50, about 11.1% above its last closing price of $89.35

This summary was machine generated from LSEG data July 30 at 09:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Jun. 30 2025
0.44
0.48
Beat
Mar. 31 2025
0.33
0.32
Missed
Dec. 31 2024
0.50
0.45
Missed
Sep. 30 2024
0.43
0.45
Beat